These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36320041)

  • 21. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species.
    Calvani M; Comito G; Giannoni E; Chiarugi P
    PLoS One; 2012; 7(10):e38388. PubMed ID: 23144690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
    Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
    Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia and its therapeutic possibilities in paediatric cancers.
    Bernauer C; Man YKS; Chisholm JC; Lepicard EY; Robinson SP; Shipley JM
    Br J Cancer; 2021 Feb; 124(3):539-551. PubMed ID: 33106581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
    Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxic tumor microenvironment: Implications for cancer therapy.
    Roy S; Kumaravel S; Sharma A; Duran CL; Bayless KJ; Chakraborty S
    Exp Biol Med (Maywood); 2020 Jul; 245(13):1073-1086. PubMed ID: 32594767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
    Jubb AM; Buffa FM; Harris AL
    J Cell Mol Med; 2010 Jan; 14(1-2):18-29. PubMed ID: 19840191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.
    Phillips RM
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):441-57. PubMed ID: 26811177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs).
    Smith PJ; McKeown SR; Patterson LH
    IUBMB Life; 2023 Jan; 75(1):40-54. PubMed ID: 35499745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.
    Tong Y; Yang H; Xu X; Ruan J; Liang M; Wu J; Luo B
    Cancer Sci; 2017 Apr; 108(4):753-762. PubMed ID: 28182306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells.
    Shi YH; Bingle L; Gong LH; Wang YX; Corke KP; Fang WG
    Pathology; 2007 Aug; 39(4):396-400. PubMed ID: 17676480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypoxia signalling pathway in haematological malignancies.
    Irigoyen M; García-Ruiz JC; Berra E
    Oncotarget; 2017 May; 8(22):36832-36844. PubMed ID: 28415662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
    Land SC; Tee AR
    J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and chronic hypoxia differentially predispose lungs for metastases.
    Reiterer M; Colaço R; Emrouznejad P; Jensen A; Rundqvist H; Johnson RS; Branco C
    Sci Rep; 2019 Jul; 9(1):10246. PubMed ID: 31308473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.